Latest
Headlines
Newsletter
Newsletter
Sign In
Home
Sign In
Sign In
Home
News
Berita
Business
Lifestyle
Opinion
World
Sports
Videos
Property
Education
Carzilla
Gallery
Accelerator
Home
News
Malaysia
Borneo+
Berita
Tempatan
Pandangan
Dunia
Business
Local Business
World Business
Lifestyle
Everyday Heroes
Travel
Food
Entertainment
Money
Health & Family
Pets
Tech
Automotive
Opinion
Column
Editorial
Letters
FMT Worldviews
World
Southeast Asia
Sports
Football
Badminton
Motorsports
Tennis
Videos
Property
Education
Carzilla
Gallery
Accelerator
Novavax
BUSINESS
Vaccine maker Novavax says ‘substantial doubt’ over future
BUSINESS
Novavax ends Covid-19 vaccine sale agreement with Gavi
WORLD
EU says Novavax Covid jab should warn of heart side effects
WORLD
EU adds severe allergies as side effect of Novavax Covid vaccine
WORLD
US authorises use of Novavax Covid-19 vaccine
WORLD
FDA troubled by potential Novavax and heart infection risk
BUSINESS
Japan approves Novavax Covid vaccine, adding fourth option
WORLD
Germans pin hopes on Novavax moving the needle among anti-vaxxers
WORLD
UK gets fifth Covid vaccine after Novavax approval
BUSINESS
Novavax to submit vaccine request to US FDA next month
WORLD
WHO approves Novavax as 10th authorised Covid jab
SOUTH EAST ASIA
Indonesia is first to approve Novavax Covid vaccine
WORLD
British study to test mixed Covid-19 vaccine dose schedules in children
WORLD
EU seals deal with Novavax for up to 200 million Covid vaccines
WORLD
Novavax Covid-19 vaccine shown to be 93% effective in US trial
WORLD
Novavax confirms ‘robust’ immune response in Beta variant vaccine
WORLD
Novavax delays Covid vaccine authorisation request to Q3
BUSINESS
Novavax inks deal to deliver 350 million Covid jabs to Covax
BUSINESS
Novavax plans to ship its vaccines to Europe by year-end
BUSINESS
Novavax shot could be approved to fight Covid-19 in US by May
WORLD
S. Korea reaches deals to buy vaccines for 23 million more people
BUSINESS
India’s Serum applies to conduct Novavax vaccine trial locally
BUSINESS
Novavax Covid vaccine highly effective, but not against S. Africa variant
BUSINESS
Questions arise as vaccine execs sell shares worth millions amidst crisis
View More